MODULATION OF ANGIOGENESIS
    1.
    发明授权

    公开(公告)号:EP2539439B1

    公开(公告)日:2018-10-17

    申请号:EP11747958.4

    申请日:2011-02-23

    CPC分类号: A61K35/545 G01N33/5008

    摘要: The invention provides methods for treating pathological conditions that can be improved by providing angiogenesis. The invention is generally directed to provide angiogenesis by administering cells that express and/or secrete one or more pro-angiogenic factors. The invention is also directed to drug discovery methods to screen for agents that modulate the ability of the cells to express and/or secrete one or more pro-angiogenic factors. The invention is also directed to cell banks that can be used to provide cells for administration to a subject, the banks comprising cells having desired levels of expression and/or secretion of one or more pro-angiogenic factors.

    MODULATION OF ANGIOGENESIS
    2.
    发明公开
    MODULATION OF ANGIOGENESIS 审中-公开
    血管生成调制

    公开(公告)号:EP2539439A1

    公开(公告)日:2013-01-02

    申请号:EP11747958.4

    申请日:2011-02-23

    IPC分类号: C12N5/074 A61P9/00

    CPC分类号: A61K35/545 G01N33/5008

    摘要: The invention provides methods for treating pathological conditions that can be improved by providing angiogenesis. The invention is generally directed to provide angiogenesis by administering cells that express and/or secrete one or more pro-angiogenic factors. The invention is also directed to drug discovery methods to screen for agents that modulate the ability of the cells to express and/or secrete one or more pro-angiogenic factors. The invention is also directed to cell banks that can be used to provide cells for administration to a subject, the banks comprising cells having desired levels of expression and/or secretion of one or more pro-angiogenic factors.

    USE OF STEM CELLS TO REDUCE LEUKOCYTE EXTRAVASATION
    4.
    发明公开
    USE OF STEM CELLS TO REDUCE LEUKOCYTE EXTRAVASATION 审中-公开
    干细胞,可降低血液白细胞外渗USE

    公开(公告)号:EP2456853A1

    公开(公告)日:2012-05-30

    申请号:EP10802840.8

    申请日:2010-07-21

    IPC分类号: C12N3/00

    摘要: The invention is generally directed to reducing inflammation by means of cells that secrete factors that reduce leukocyte extravasation. Specifically, the invention is directed to methods using cells that secrete factors that downregulate the expression of cellular adhesion molecules in vascular endothelial cells. Downregulating expression of cellular adhesion molecules reduces leukocyte adhesion to the endothelial cells such that extravasation is reduced. The end result is a reduction of inflammation. The cells are non-embryonic non-germ cells that have pluripotent characteristics. These may include expression of pluripotential markers and broad differentiation potential.